The Hershey Company recently highlighted a surprising uptick in their sales of mints and gum, which they attribute to the rising prevalence of weight-loss drugs and the consequent shift in consumers’ snacking habits. The company noted that the demand for products that freshen breath has grown in tandem with the trends toward “functional snacking” associated with the consumption of medications like Ozempic and Wegovy.
Kirk Tanner, Hershey’s CEO, stated, “We’ve noticed a robust demand for gum and mints as they benefit from the tailwinds of functional snacking, influenced by the adoption of GLP-1 medications.” He also pointed out that the retail sales for Ice Breakers, the company’s third-largest confection brand, saw an increase of over 8% during the quarter.
While the Hershey Company did not directly associate this trend with specific side effects, it is worth noting that some consumers taking GLP-1 medications have reported experiencing halitosis, colloquially referred to as ‘Ozempic breath’. Medical professionals suggest that this could be due to dry mouth resulting from dehydration or changes in saliva production, notwithstanding the fact that it is not officially listed as a side effect.
This shift in consumption habits has not only impacted the mint and gum market but has also influenced other sections of the snacking industry. For instance, premium chocolate manufacturer Lindt & Sprungli has reported a marked increase in US sales among GLP-1 users. Similarly, Magnum Ice Cream Company has noticed that the trend is bolstering the demand for smaller, higher-quality snacks.
Peter ter Kulve, the CEO of Magnum Ice Cream Company, said, “As consumers who use GLP-1s are eliminating lower-quality snacking options first, categories such as premium chocolate, premium ice cream, and protein snacks could potentially acquire a larger share of the overall snacking market.”
Questions & Answers
**What has been the trend in Hershey’s sales of mints and gum?**
Hershey’s has observed an unexpected surge in their sales of mints and gum, which they attribute to changing consumption patterns due to the increased use of weight-loss drugs.
**What are the potential reasons for the ‘bad breath’ experienced by some users of GLP-1 medications?**
Medical professionals suggest that the bad breath experienced by some users of GLP-1 medications could be due to dry mouth resulting from dehydration or changes in saliva production.
**How has the shift in snacking habits influenced other sectors of the snacking industry?**
The shift in consumption patterns is supporting the demand for smaller, higher-quality snacks in other sectors of the industry. Companies like Lindt & Sprungli and Magnum Ice Cream Company have reported increased sales among users of GLP-1 medications.
